Author:
Aguiar Maíra,Anam Vizda,Cusimano Nicole,Knopoff Damián,Stollenwerk Nico
Publisher
Springer International Publishing
Reference61 articles.
1. M. Aguiar, N. Stollenwerk, Dengvaxia efficacy dependency on serostatus: a closer look at more recent data. Clin. Infect. Dis. 66(4), 641–642 (2018)
2. M. Aguiar, N. Stollenwerk, Dengvaxia: age as surrogate for serostatus. Lancet Infect. Dis. 18(3), 245 (2018)
3. M. Aguiar, N. Stollenwerk, Condition-specific mortality risk can explain differences in COVID-19 case fatality ratios around the globe. Publ. Health 188, 18–20 (2020)
4. M. Aguiar, N. Stollenwerk, SHAR and effective SIR models: from dengue fever toy models to a COVID-19 fully parametrized SHARUCD framework. Commun. Biomath. Sci. 3(1), 60–89 (2020)
5. M. Aguiar, N. Stollenwerk, The impact of serotype cross-protection on vaccine trials: DENVax as a case study. Vaccines 8, 674 (2020)
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献